STOCK TITAN

Cryomass Technologies Inc Stock Price, News & Analysis

CRYM OTC

Welcome to our dedicated page for Cryomass Technologies news (Ticker: CRYM), a resource for investors and traders seeking the latest updates and insights on Cryomass Technologies stock.

Cryomass Technologies Inc (CRYM) delivers innovative cryogenic solutions for optimizing cannabis and hemp processing through its patented CryoSift Separator™ technology. This dedicated news hub provides investors and industry professionals with essential updates on the company developments shaping biomass refinement standards.

Access authoritative coverage of CRYM's strategic partnerships, equipment innovations, and operational milestones. Our curated news collection features press releases regarding patent advancements, processing agreements with industry leaders, and efficiency breakthroughs in trichome separation systems.

Key updates include earnings reports, technology deployments, regulatory compliance developments, and partnership expansions with vertically integrated operators. All content is verified for accuracy and relevance to maintain your informed perspective on cryogenic refinement advancements.

Bookmark this page for real-time updates on CRYM's progress in transforming post-harvest processing through liquid nitrogen technology. Regularly refreshed content ensures you stay current with developments impacting the cannabis processing sector and industrial biomass refinement markets.

Rhea-AI Summary

CryoMass Technologies Inc. (OTCQB: CRYM) has announced the sale of a CryoSift Separator™ production model to Tribe Collective, with shared usage rights granted to Choctaw Processing in the Oklahoma cannabis market. The deal includes non-exclusive patent license agreements with both companies for at least five years.

The transaction structure combines one-time revenue from equipment sale and recurring processing fees based on biomass volume, with potential recurring revenues exceeding $1,000,000 annually. The sale was facilitated through financing from NEC Financial Services,

This shared-usage model demonstrates CryoMass's ability to create value for multiple operators within competitive markets by enabling cost reductions and improved extraction efficiency. The technology adoption by established operators validates its potential to transform harvest and post-harvest operations while establishing a recurring revenue model for CryoMass.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.21%
Tags
none
-
Rhea-AI Summary

CryoMass Technologies announced the sale of its second CryoSift Separator™ for $1.2 million to LEEF Brands, a major vertically integrated cannabis company in California. This sale is part of a multi-party Equipment Lease and Non-Exclusive Patent License agreement facilitated by a Non-Dilutive Financing Agreement with CRYM Co-Invest GP. The partnership highlights LEEF's commitment to innovation and efficiency in biomass refinement, aligning with CryoMass's pioneering cryogenic technology. This collaboration is a significant milestone for CryoMass, reinforcing its position in the cannabis industry.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
50.61%
Tags
partnership
-
Rhea-AI Summary

CryoMass Technologies announced the sale of its first CryoSift Separator™ production model for CAD$1.62 million, to be deployed in Canada. The sale is part of a multi-party Equipment Lease and Non-Exclusive Patent License agreement, which will also generate recurring revenue from processing fees. The new modular system dramatically reduces biomass volume by 65% and enhances both performance and versatility. The buyer has 60 days to complete the payment. This marks a significant milestone in CryoMass's growth strategy and aims to introduce its cryogenic technology to Canada's mature cannabis market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
20%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
32.5%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.16%
Tags
partnership
-
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.38%
Tags
none
Rhea-AI Summary

CryoMass Technologies Inc. (OTCQX: CRYM) announced the signing of a multi-state license agreement with RedTape Core Partners LLC on January 18, 2023. This follows the delivery of CryoMass' Trichome Separation unit to RedTape's facility in Monterrey, California, for beta testing.

The licensed agreement includes a total investment of US$10.2 million over 2023 for the deployment of 12 Trichome Separation systems. The partnership aims to enhance hemp and cannabis processing capabilities across California, New York, New Jersey, Florida, and Pennsylvania.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.35%
Tags
none
-
Rhea-AI Summary

CryoMass Technologies (OTC: CRYM) announced the Canadian Intellectual Property Office granted it a patent (#3064896) for a novel cryogenic separation process for plant material, valid until 2039. This patent follows similar protections granted in the U.S. and China, effective until 2038. CEO Christian Noël emphasized the significance of this patent in the booming $50 billion cannabis/hemp industry and its potential applications across agriculture. The company aims to enhance its global patent portfolio, including upcoming applications in the European Union.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.05%
Tags
none
-
Rhea-AI Summary

CryoMass Technologies has initiated real-time trials for its patented cryogenic system designed for extracting high-value elements from hemp and cannabis plants. The system, measuring 160 square feet and operating with ultra-cold liquid nitrogen, aims to enhance efficiency and quality in cannabinoid capture. Preliminary results show throughput rates of 400-600 kg/hour and a capture rate of 96-97%. The company believes the device offers significant advantages over conventional methods, which typically incur a loss of around one-third of cannabinoids.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.49%
Tags
none
Rhea-AI Summary

CryoMass Technologies Inc. has initiated real-time trials of its patented cryogenic system for hemp and cannabis extraction. The equipment, which measures 160 square feet and operates at ultra-cold temperatures, aims to maximize cannabinoid capture and efficiency. Preliminary results show a throughput of 400-600 kg/hour and a cannabinoid capture rate between 96% and 97%. The system promises significant time and cost savings over traditional methods, potentially benefiting large-scale cultivators and processors of botanicals.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.49%
Tags
none

FAQ

What is the current stock price of Cryomass Technologies (CRYM)?

The current stock price of Cryomass Technologies (CRYM) is $0.028325 as of May 7, 2025.

What is the market cap of Cryomass Technologies (CRYM)?

The market cap of Cryomass Technologies (CRYM) is approximately 6.5M.
Cryomass Technologies Inc

OTC:CRYM

CRYM Rankings

CRYM Stock Data

6.45M
199.87M
15.72%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Denver